Citadel Advisors’s POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO XLVS Stock Holding History
Bought
Maintained
Sold
Other funds holding XLVS
LTFS
UCFA
CCMG
CAS
RJA
FLAM
Citadel Advisors's XLVS Position: Q2 2017 in Review
Citadel Advisors sold out of POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO (XLVS) in Q2 2017, closing a stake of 14,912 shares — an estimated $1.19M sold.
Citadel Advisors first reported a position in XLVS in Q2 2015 and held it in 8 quarters. The position peaked at $3.53M in Q4 2016. 55 funds tracked by Wall St. Rank hold XLVS as of Q2 2017.
- Citadel Advisors reported no remaining POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO position as of Q2 2017 after selling out during the quarter.
- Citadel Advisors sold 14,912 POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO shares in Q2 2017, an estimated $1.19M.
- Citadel Advisors first reported a position in POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO in Q2 2015 and held it in 8 quarters.
- Citadel Advisors's POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO position peaked at $3.53M in Q4 2016.
- 55 funds tracked by Wall St. Rank held POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO as of Q2 2017.
Based on Citadel Advisors's 13F filing for Q2 2017, filed 11 Aug 2017.